Classifications

• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
  • A23C9/00—Milk preparations; Milk powder or milk powder preparations
  • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
  • A23C21/00—Whey; Whey preparations
  • A23C21/06—Mixtures of whey with milk products or milk components
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
  • A23C9/00—Milk preparations; Milk powder or milk powder preparations
  • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
  • A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
  • A23C9/1206—Lactose hydrolysing enzymes, e.g. lactase, beta-galactosidase
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
  • A23C9/00—Milk preparations; Milk powder or milk powder preparations
  • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
  • A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
  • A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
  • A23C9/00—Milk preparations; Milk powder or milk powder preparations
  • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
  • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
  • A23C9/00—Milk preparations; Milk powder or milk powder preparations
  • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
  • A23C9/142—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
  • A23C9/1422—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of milk, e.g. for separating protein and lactose; Treatment of the UF permeate
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
  • A23C9/00—Milk preparations; Milk powder or milk powder preparations
  • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
  • A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
  • A23C9/1465—Chromatographic separation of protein or lactose fraction; Adsorption of protein or lactose fraction followed by elution
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
  • A23C9/00—Milk preparations; Milk powder or milk powder preparations
  • A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
  • A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
• • A—HUMAN NECESSITIES
  • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
  • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
  • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
  • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
  • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
  • A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
  • A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose

Definitions

• the invention relates to a low-energy, non-fat milk beverage of high calcium content and to a method for preparing such a beverage.
• a primary source of energy for humans consists of carbohydrates, proteins and fats.
• An essential aspect in weight loss is to reduce the amount of energy supplied by the diet.
• energy balance is the most critical factor. Reports from research made in recent years suggest that calcium, fibre, vitamin D and certain protein components of milk may have an effect on energy balance control.
• Milk products are generally useful for lowering the glycaemic index of the diet. This means that the glucose level of blood after a meal does not rise as high as it would if the meal contained a lot of highly processed carbohydrates, i.e. products of high glycaemic index.
• a diet rich in products of high glycaemic index has been associated with central obesity, cardiovascular disease and type-2 diabetes.
• WO 2004/075666 A2 relates to a reduced carbohydrate milk product and a method for preparing it.
• the raw material in this product is ultra filtered milk containing about 1 to 3% of carbohydrates, about 3 to 7% of proteins and 3 to 5% of fat.
• the milk product may also contain calcium, flavouring and sweeteners, for example.
• An advantage of the milk beverage of the invention is that it combines an optimal composition of nutrients that have a positive effect on weight control and on dietary treatment of diabetes and metabolic syndrome.
• the non-fat milk beverage of the invention has a low carbohydrate content and thereby an extremely low energy content, while its composition and taste still correspond to that of ordinary non-fat milk.
• Figure 1 is a block diagram illustrating a method according to one embodiment of the invention.
• the invention relates to a low-energy, non-fat milk beverage characterized in that it contains a low-energy milk base, which consists of nonfat milk, a whey protein solution, or a mixture of the two and from which carbohydrates have been removed either partly or totally, and in that it is rich in calcium.
• a low-energy milk base which consists of nonfat milk, a whey protein solution, or a mixture of the two and from which carbohydrates have been removed either partly or totally, and in that it is rich in calcium.
• the protein content of milk contains 80% of casein proteins and 20% of whey proteins. Due to its amino acid composition and satiety- increasing effect, a whey protein fraction included in foodstuffs has been observed to have an advantageous effect on the metabolic syndrome and weight control. Compared with caseins and other protein sources, whey protein increases satiety and reduces the amount of food intake during subsequent meals.
• the raw material used in the milk beverage of the invention is nonfat milk, a whey protein solution, or a mixture combining the two in any proportion.
• the milk base preferably consists of 100 to 10% of non-fat milk and 0 to 90% of whey protein solution, more preferably 70 to 50% of non-fat milk and 30 to 50% of whey protein solution.
• the milk beverage of the invention is fat-free, the amount of fat it contains is less than 0.5%.
• Carbohydrates are removed from the above raw material either entirely or partly to produce a low-energy product. This is done either by ultrafiltration or chromatographically according to known methods such that the total energy content of the milk beverage does not exceed 20 kcal/100g.
• Carbohydrates of milk are mainly derived from lactose.
• the preparation of a low-lactose or lactose-free milk product has been described in Fl Application 20020907, for example.
• the salt content of the milk beverage must be returned to its original level by adding ordinary table salt or milk salts, for example.
• Preferably, only part of the lactose is removed such that the maximum final lactose content in the milk beverage of the invention is about 1.7g/100g of the milk beverage. If lactose is left in the final milk beverage, it is preferably hydrolysed to break down the lactose into glucose and galactose.
• lactase ⁇ -galactosidase
• lactose contributes to the organoleptic properties of the milk beverage of the invention by providing sweetness and, thereby, improving the taste of the product.
• the removal of carbohydrates or the reduction of an amount thereof from the raw material consisting of non-fat milk and/or whey protein results in what is known as a low-energy milk base.
• This milk base may then be complemented by soluble fibre.
• Fibre may have an impact on energy control through a plural number of mechanisms. First, fibre reduces the energy density of food. Fibre may also cause the stomach to expand due to increased salivation and secretion of gastric acid.
• Soluble fibre slows the evacuation of the stomach by forming a viscous gel matrix that contains nutrients and slows down the release of food from the stomach. This slows down digestion, whereby nutrients are absorbed more uniformly and the feeling of satiety lasts longer.
• Fibre may act on energy balance also through a hormonal mechanism. Fibre, and soluble fibre in particular, reduce the absorption of fat and protein possibly by reducing the physical contact between nutrients and the villi in the intestines.
• the fibre in the milk beverage of the invention increases satiety by adding volume to the food mass.
• An increase in the daily intake of fibre reduces energy intake and thereby causes weight loss in the long term.
• Positive effects are achieved both by means of fibre obtained from natural sources and from a fibre supplement.
• Fibre also improves taste and thereby contributes to the organoleptic properties of the milk beverage of the invention.
• Examples of soluble fibre that may be added to the milk beverage of the invention include polydextrose, inulin, fructooligosaccharides, galactooligosaccharides, pectin, ⁇ -glucan, guar gum, xanthan gum, carrageen, and carob powder. Polydextrose is preferred.
• the maximum amount of added fibre is 3g/100g of the milk beverage, preferably 1.5g/100g.
• the milk beverage of the invention is rich in calcium. As disclosed above, calcium has been discovered to have a positive effect on weight control. Calcium may be added to the milk beverage in different forms, for example in the form of Ca lactate gluconate, milk calcium, Ca gluconate, Ca lactate, Ca citrate or in some other soluble form of calcium salt.
• the milk beverage of the invention contains 120 to 240mg of calcium in 100g of the milk beverage, preferably 180mg/100g, which is 1.5 times the amount naturally contained in milk.
• the milk beverage of the invention may also contain vitamin D.
• Vitamin D enhances calcium absorption and thereby, through calcium, has an indirect effect on energy balance.
• the amount of vitamin D in the milk beverage of the invention may be 0.1 to 1 ⁇ g/100g, preferably 0.5 ⁇ g/100g.
• sweeteners and flavours may also be added to the beverage.
• suitable sweeteners include fructose, sucralose, acesulfame-K, aspartame, saccharine, and cyclamate.
• the invention also relates to a method for preparing a low- energy, non-fat milk beverage of a high calcium content as described above.
• non-fat milk, a whey protein solution, or a mixture of the two is ultra- filtered or, alternatively, evaporated and subjected to chromatography to remove carbohydrates or to reduce the amount thereof; any remaining carbohydrates are hydrolysed, if desired; fibre and vitamin D as well as any other additives, such as water, salt, sweetener, flavour, and other vitamins, are added; the mixture thus obtained is subjected to pasteurisation, ultra pasteurisation or ultra high temperature treatment at a temperature of 72 to 145°C; the mixture is homogenised; and calcium is added to the mixture.
• the raw material formed by the non-fat milk, the whey protein solution, or the mixture of the two is evaporated to a solids content of about 10 to 70%, preferably about 20 to 50%, more preferably about 30 to 40%.
• carbohydrates are removed from the concentrate or their amount is reduced by means of chromatography such that the total energy content of the remaining components does not exceed 20 kcal/100g.
• carbohydrates are removed from the raw material by ultrafiltration. Remaining carbohydrates, i.e. mainly lactose, are preferably hydrolysed to introduce sweetness into the milk beverage and thereby improve its taste. If desired, salts, sweeteners and flavour may be added to the milk beverage to further improve its organoleptic properties.
• the mixture is then subjected to pasteurisation, ultra pasteurisation (ESL) or ultra high temperature treatment (UHT) at a temperature of 72 to 145°C and homogenized in a pressure of 100 to 160 bars. Finally, calcium is added. To prevent proteins from precipitating in the thermal processing, this must be done after pasteurisation.
• ESL ultra pasteurisation
• UHT ultra high temperature treatment
• the raw material used in the milk beverage of the invention ("weight control drink") is non-fat milk. A portion of the carbohydrates contained therein is removed by means of chromatographic separation or by ultrafiltration. [0025] 1. A milk protein solution prepared by means of chromatography
• Non-fat milk is evaporated to a dry solids content of 30g/100g.
• a protein fraction having a carbohydrate (lactose) content of about 1.6g/100g and containing most of the milk salts is separated from the evaporated milk by means of chromatography.
• the compositions of the feed solution and the protein fraction are given in Table 1
• Non-fat milk is supplied through an ultrafiltration device to obtain a retentate containing mainly milk proteins, lactose and a portion of the milk salts.
• the composition of the UF-retentate (the milk protein concentrate) is given in Table 2.
• the milk beverage of the invention is composed according to the following recipe:
• the milk protein solution and the milk protein concentrate are hydrolysed enzymatically by means of a lactase enzyme in a container at a temperature of about 10°C for about 10 hours.
• water, milk salts and polydextrose are added under stirring to the milk protein mixture in the container.
• the solution is supplied through an ultra pasteurisation device (ESL, temperature 127°C, duration ⁇ 1 sec.) and a homogeniser (pressure 160 bars).
• ESL ultra pasteurisation device
• the calcium lactate gluconate is dissolved in hot water (in a proportion of 1 :4 by mass) in a separate container and the solution is pumped into the milk-based solution into the product flow.
• the entire product is pumped into an aseptic package and forwarded to packaging.
• a milk beverage of the invention having a composition as shown in Table 3 is obtained.
• Example 2 The raw material in the milk beverage of the invention ("weight control drink”) is non-fat milk and a whey protein solution in a proportion of 10:90.
• the product is prepared by removing most of the carbohydrates in the non-fat milk and the whey protein solution by means of chromatographic separation.
• Sweet whey obtained in cheese manufacture is nanofiltered to produce a whey protein solution in which the amount of whey proteins is about 3.3g/100g.
• the whey protein solution in question and the non-fat milk are combined so that about 10% of the total protein content of the mixture consists of proteins obtained from the non-fat milk and about 90% from proteins of the whey protein solution.
• the milk protein-whey protein solution is evaporated to a dry solids content of about 40g/100g.
• a protein fraction having a carbohydrate (lactose) content of about 1.6g/100g and containing a portion of the salts of the milk and the whey is separated chromatographically from the evaporated mixture.
• the compositions of the feed solution and the protein fraction are given in Table 4.
• the milk beverage of the invention is composed according to the following recipe: 79.000% protein fraction 19.329% water 1.670% polydextrose (Litesse Ultra, Danisco) 0.001% vitamin D solution (Kemikalia)
• the protein fraction is hydrolysed enzymatically (by means of a lactase enzyme) in a container at a temperature of about 10°C for about 10 hours. After the hydrolysis, water and polydextrose are added under stirring to the protein mixture in the container. The solution is supplied through an ultra pasteurisation device (ESL, temperature 127°C, duration ⁇ 1 sec.) and a homogeniser (pressure 160 bars). The calcium lactate gluconate is dissolved in hot water (in a proportion of 1 :4 by mass) in a separate container and the solution is pumped into the milk-based solution into the product flow. The entire product is pumped into an aseptic package and forwarded to packaging. As a result, a milk beverage of the invention having a composition as shown in Table 5 is obtained.
• the raw material in the milk beverage of the invention (“weight control drink”) is non-fat milk and a whey protein solution in a proportion of 60:40.
• the product is prepared by removing a portion of the carbohydrates in the non-fat milk and the whey protein solution by means of a chromatographic separation.
• Sweet whey obtained in cheese manufacture is nanofiltered to produce a whey protein solution in which the amount of whey proteins is about 3.3g/100g.
• the whey protein solution in question and the non-fat milk are combined so that about 60% of the total protein content of the mixture consists of proteins obtained from the non-fat milk and about 40% of the proteins from the whey protein solution.
• the milk protein-whey protein solution is evaporated to a dry solids content of about 35g/100g.
• a protein fraction having a carbohydrate (lactose) content of about 1.6g/100g and containing a portion of the salts of the milk and the whey is separated chromatographically from the evaporated mixture.
• the compositions of the feed solution and the protein fraction are given in Table 6.
• the milk beverage of the invention is composed according to the following recipe: 74.000% protein fraction 24.236% water 1.670% polydextrose (Litesse Ultra, Danisco) 0.093% calcium lactate gluconate (Puracal Xperform, Purac) 0.001% vitamin D solution (Kemikalia)
• the protein fraction is hydrolysed enzymatically (by means of a lactase enzyme) in a container at a temperature of about 10°C for about 10 hours. After the hydrolysis, water and polydextrose are added under stirring to the protein mixture in the container. The solution is supplied through an ultra pasteurisation device (ESL, temperature 127°C, duration ⁇ 1 sec.) and a homogeniser (pressure 160 bars). The calcium lactate gluconate is dissolved in hot water (in a proportion of 1 :4 by mass) in a separate container and the solution is pumped into the milk-based solution into the product flow. The entire product is pumped into an aseptic package and forwarded to packaging. As a result, a milk beverage of the invention having a composition as shown in Table 7 is obtained.

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Food Science & Technology (AREA)
• Polymers & Plastics (AREA)
• Health & Medical Sciences (AREA)
• Molecular Biology (AREA)
• Microbiology (AREA)
• Nutrition Science (AREA)
• Water Supply & Treatment (AREA)
• Biochemistry (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Analytical Chemistry (AREA)
• Mycology (AREA)
• Inorganic Chemistry (AREA)
• Dairy Products (AREA)
• Coloring Foods And Improving Nutritive Qualities (AREA)
• Non-Alcoholic Beverages (AREA)

Priority Applications (12)

Applications Claiming Priority (2)

Publications (1)

Family

ID=34224286

Family Applications (1)

Country Status (18)

Cited By (10)

Families Citing this family (8)

Citations (10)

Family Cites Families (10)

• 2005
  • 2005-02-18 FI FI20055076A patent/FI120616B/fi not_active IP Right Cessation
  • 2005-12-08 BR BRPI0520131-4A patent/BRPI0520131A2/pt not_active IP Right Cessation
  • 2005-12-08 ES ES05817672T patent/ES2340052T3/es not_active Expired - Lifetime
  • 2005-12-08 CN CNA2005800481195A patent/CN101119637A/zh active Pending
  • 2005-12-08 CA CA002597358A patent/CA2597358A1/en not_active Abandoned
  • 2005-12-08 DK DK05817672.8T patent/DK1848285T3/da active
  • 2005-12-08 DE DE602005019477T patent/DE602005019477D1/de not_active Expired - Lifetime
  • 2005-12-08 JP JP2007555650A patent/JP2008529547A/ja active Pending
  • 2005-12-08 AT AT05817672T patent/ATE457648T1/de not_active IP Right Cessation
  • 2005-12-08 WO PCT/FI2005/050454 patent/WO2006087409A1/en not_active Ceased
  • 2005-12-08 US US11/884,533 patent/US20080268100A1/en not_active Abandoned
  • 2005-12-08 MX MX2007009979A patent/MX2007009979A/es not_active Application Discontinuation
  • 2005-12-08 KR KR1020077021448A patent/KR20070114175A/ko not_active Withdrawn
  • 2005-12-08 RU RU2007134563/13A patent/RU2007134563A/ru not_active Application Discontinuation
  • 2005-12-08 PL PL05817672T patent/PL1848285T3/pl unknown
  • 2005-12-08 AU AU2005327803A patent/AU2005327803A1/en not_active Abandoned
  • 2005-12-08 EP EP05817672A patent/EP1848285B1/en not_active Expired - Lifetime
• 2007
  • 2007-09-18 NO NO20074769A patent/NO20074769L/no not_active Application Discontinuation

Patent Citations (10)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events